Improved quality of life in patients with no-option critical limb ischemia undergoing gene therapy with DVC1-0101

Critical limb ischemia (CLI) has a poor prognosis and adversely affects patients’ quality of life (QOL). Therapeutic angiogenesis may improve mobility, mortality, and QOL in CLI patients. However, the effectiveness of gene therapy on such patients’ QOL is unknown. DVC1-0101, a non-transmissible reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Takuya, Tanaka, Michiko, Yoshiya, Keiji, Yoshiga, Ryosuke, Matsubara, Yutaka, Horiuchi-Yoshida, Kumi, Yonemitsu, Yoshikazu, Maehara, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945920/
https://www.ncbi.nlm.nih.gov/pubmed/27418463
http://dx.doi.org/10.1038/srep30035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945920/
https://www.ncbi.nlm.nih.gov/pubmed/27418463
http://dx.doi.org/10.1038/srep30035

Ejemplares similares